ArticleRadiation oncology journal2022

A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer.

Sergey Nikolaevich Novikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.